NASDAQ-Listed Cannabis Giant Misses Tech Rally: What Investors Need To Know About MAPS' Stock

Zinger Key Points
  • Senior analyst Pablo Zuanic noted that SaaS solution revenues surged 19%, contributing to 29% of the total revenue mix.
  • Zuanic highlighted potential opportunities for MAPS to monetize additional touchpoints on the Weedmaps platform.

WM Technology MAPS has maintained stability in its profitability and cash flow, showcasing a 3% sequential sales increase to $45.9 million for 2Q24, despite a 5% year-over-year decline.

In a Monday afternoon report, senior analyst Pablo Zuanic noted that SaaS solution revenues, representing WM Technology’s software offerings for cannabis businesses, surged 19%, contributing to 29% of the total revenue mix. Meanwhile, listing revenues, which account for 62% of the mix and primarily come from featured listings and deals on the Weedmaps platform, fell 14% year-over-year. Zuanic & Associates reiterated a “Neutral” rating for WM Technology, but “are becoming more constructive.”

The company's adjusted EBITDA margins remained stable at 22%, with average monthly paying clients increasing by 2% to 5,045.

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can’t afford to miss out if you're serious about the business.

Cost Controls And Reinvestment Drive Growth

MAPS has been reinvesting cost savings into advertising and product development, with ad spending reaching 8.3% of revenue in 2Q24, up from 5.6% in 1Q24. Meanwhile, cash General and Administrative (G&A) expenses fell 3% sequentially. Zuanic noted that cash reserves increased by $5.5 million to $41.2 million, with receivables reduced to 14 days from 28 days in 2Q23.

Competitive Position Outside California

While MAPS has shown strong performance in its home state of California, Zuanic raised concerns about the company's ability to compete in other markets. Michigan has been a notable bright spot, but it remains an exception rather than the rule.

Read Also: Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

Opportunities To Monetize Additional Platform Features

Zuanic highlighted potential opportunities for MAPS to monetize additional touchpoints on the Weedmaps platform. This could include expanding into adjacent cannabis categories, depending on how regulations evolve.

According to Zuanic, there may be opportunities to "monetize other touchpoints in the Weedmaps platform or enter adjacent MJ categories," which could present further growth avenues for the company as regulations change.

Outlook And Valuation

For 3Q24, MAPS expects sales of $44 million, with EBITDA margins projected to decline to 16%. According to Zuanic, in the medium term, the company targets a return to 20% EBITDA margins.

Valued at 1.2x sales and 12.8x EBITDA, MAPS currently lags behind peers in the tech sector, with non-cannabis marketplace stocks trading at 2.6x sales, e-commerce enablement platforms at 3.6x and vertical SaaS stocks at over 7x. However, Zuanic emphasized the company's focus on cost control and its pursuit of growth in emerging markets, positioning it for future opportunities.

Read Next: More Than $3 Billion At Stake: How Regulatory Red Tape Is Holding Back Australia’s Cannabis Legalization

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisNewsSmall Cap AnalysisSmall CapMarketsAnalyst RatingsTechTrading Ideascannabis SaaScannabis stocksPablo ZuanicSAASSaaS platformWeedmaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.